Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$1.05 - $2.9 $31,718 - $87,603
30,208 New
30,208 $87,000
Q2 2023

Jul 11, 2023

BUY
$2.07 - $2.92 $69,115 - $97,495
33,389 New
33,389 $71,000
Q2 2022

Jul 12, 2022

BUY
$2.09 - $3.71 $114,421 - $203,111
54,747 New
54,747 $175,000
Q1 2020

Apr 09, 2020

SELL
$1.28 - $4.5 $94,543 - $332,379
-73,862 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$4.03 - $9.22 $297,663 - $681,007
73,862 New
73,862 $331,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $47.3M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.